Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation

PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Mechanical VentilationSedationCritical IllnessCOVID
Interventions
DRUG

Propranolol Hydrochloride

"Propranolol enterally at a starting dose of 20mg every 6h for 2-4 doses, and then re-assessed for upwards titration every 24 hours (+/- 6 hours) at 10mg dose increases depending on clinical response. Maximum dose of 60mg every 6h. Titration decision to be made by clinical team at daily rounds.~Daily titration will be guided by hemodynamic markers indicative of the expected sympatholysis from propranolol. Upward titration of propranolol should coincide with a downward titration in sedatives until a minimum level of sedative infusion is reached (propofol \<0.5mg/kg/h or midazolam \<1.0mg/h). Nurses will be instructed at each assessment to determine if sedative targets can be achieved with lower doses of sedatives. Daily upward titration of propranolol will be recommended if none of these conditions are met: (1)HR\<70 beats/min, (2) Mean Arterial Pressure \<70 mmHg or (3) norepinephrine or equivalent vasopressor dose increase to \>0.15 mcg/kg/min."

Trial Locations (2)

L8L2X2

Hamilton Health Sciences Centre - Hamilton General Hospital, Hamilton

K1H8M8

The Ottawa Hospital, Ottawa

All Listed Sponsors
collaborator

Hamilton Health Sciences Corporation

OTHER

collaborator

The Ottawa Hospital

OTHER

collaborator

McMaster University

OTHER

collaborator

Sinai Health System

OTHER

lead

Ottawa Hospital Research Institute

OTHER